| Primary |
| Meningitis Cryptococcal |
60.0% |
| Fungal Infection |
40.0% |
|
| Renal Impairment |
40.0% |
| Drug Interaction |
20.0% |
| Hepatic Function Abnormal |
20.0% |
| Lactic Acidosis |
20.0% |
|
| Secondary |
| Sepsis |
18.4% |
| Hypertension |
10.4% |
| Crohn's Disease |
9.0% |
| Drug Use For Unknown Indication |
6.4% |
| Product Used For Unknown Indication |
6.0% |
| Interstitial Lung Disease |
5.6% |
| Pneumonia |
5.6% |
| Sedation |
5.2% |
| Pneumonia Staphylococcal |
4.2% |
| Gastric Ulcer |
3.2% |
| Infection Prophylaxis |
3.2% |
| Peritonitis |
3.2% |
| Systemic Mycosis |
3.0% |
| Upper Respiratory Fungal Infection |
3.0% |
| Pyrexia |
2.6% |
| Staphylococcal Infection |
2.6% |
| Meningitis Tuberculous |
2.4% |
| Cancer Pain |
2.0% |
| Fungal Infection |
2.0% |
| Meningitis Cryptococcal |
1.8% |
|
| Toxic Epidermal Necrolysis |
24.8% |
| Pyrexia |
15.2% |
| White Blood Cell Count Decreased |
7.6% |
| Sepsis |
6.7% |
| Vomiting |
6.7% |
| Inappropriate Antidiuretic Hormone Secretion |
3.8% |
| Interstitial Lung Disease |
3.8% |
| Platelet Count Decreased |
3.8% |
| Drug Eruption |
2.9% |
| Eosinophilic Pneumonia |
2.9% |
| Hepatic Failure |
2.9% |
| Pancytopenia |
2.9% |
| Small Intestine Carcinoma |
2.9% |
| Anaemia |
1.9% |
| Hepatic Function Abnormal |
1.9% |
| Multi-organ Failure |
1.9% |
| Oral Mucosal Disorder |
1.9% |
| Respiratory Depression |
1.9% |
| Septic Shock |
1.9% |
| Thrombocytopenia |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
15.7% |
| Prophylaxis |
15.2% |
| Product Used For Unknown Indication |
15.1% |
| Pneumonia |
7.7% |
| Infection Prophylaxis |
5.2% |
| Interstitial Lung Disease |
4.5% |
| Constipation |
3.8% |
| Sepsis |
3.5% |
| Stem Cell Transplant |
3.4% |
| Immunosuppression |
3.1% |
| Pyrexia |
2.6% |
| Disseminated Intravascular Coagulation |
2.5% |
| Allogenic Bone Marrow Transplantation Therapy |
2.4% |
| Cancer Pain |
2.4% |
| Acute Myeloid Leukaemia Recurrent |
2.3% |
| Insomnia |
2.3% |
| Multiple Myeloma |
2.2% |
| Hypertension |
2.1% |
| Premedication |
2.1% |
| Pulmonary Mycosis |
1.8% |
|
| White Blood Cell Count Decreased |
14.9% |
| Sepsis |
10.3% |
| Platelet Count Decreased |
8.0% |
| Renal Impairment |
7.4% |
| Agranulocytosis |
5.7% |
| Hepatic Function Abnormal |
5.7% |
| Interstitial Lung Disease |
5.1% |
| Shock |
5.1% |
| Pneumonia |
4.6% |
| Liver Disorder |
4.0% |
| Toxic Epidermal Necrolysis |
4.0% |
| Renal Failure Acute |
3.4% |
| Tuberculosis |
3.4% |
| Pyrexia |
2.9% |
| Thrombocytopenia |
2.9% |
| Venoocclusive Liver Disease |
2.9% |
| Vomiting |
2.9% |
| Enterocolitis Haemorrhagic |
2.3% |
| Retinal Haemorrhage |
2.3% |
| Vena Cava Thrombosis |
2.3% |
|
| Interacting |
| Cardiac Failure |
25.0% |
| Systemic Candida |
25.0% |
| Acute Promyelocytic Leukaemia |
12.5% |
| Agranulocytosis |
12.5% |
| Atrial Fibrillation |
12.5% |
| Basedow's Disease |
12.5% |
|
| Hypercalcaemia |
50.0% |
| International Normalised Ratio Increased |
50.0% |
|
